BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29307797)

  • 1. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis.
    Nguyen L; Masouminia M; Mendoza A; Samadzadeh S; Tillman B; Morgan T; French B; French S
    Exp Mol Pathol; 2018 Feb; 104(1):45-49. PubMed ID: 29307797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
    Jia Y; French B; Tillman B; French S
    Exp Mol Pathol; 2018 Aug; 105(1):144-149. PubMed ID: 30009772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
    Jia Y; Ji P; French B; Tillman B; French SW
    Exp Mol Pathol; 2019 Jun; 108():156-163. PubMed ID: 30951700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.
    Lu JG; Nguyen L; Samadzadeh S; Masouminia M; Mendoza A; Sweeney O; Tillman B; Afifyan N; Morgan T; French BA; French SW
    Exp Mol Pathol; 2018 Apr; 104(2):125-129. PubMed ID: 29425759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
    Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
    Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis.
    Mendoza AS; Dorce J; Peng Y; French BA; Tillman B; Li J; French SW
    Exp Mol Pathol; 2015 Feb; 98(1):65-72. PubMed ID: 25526666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights.
    Qin J; Higashi T; Nakagawa S; Fujiwara N; Yamashita YI; Beppu T; Baba H; Kobayashi M; Kumada H; Gunasekaran G; Schiano TD; Thung SN; Fiel MI; Hoshida Y; Ward SC
    Am J Surg Pathol; 2020 Oct; 44(10):1406-1412. PubMed ID: 32618599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).
    Liu H; Gong M; French BA; Li J; Tillman B; French SW
    Exp Mol Pathol; 2014 Dec; 97(3):477-83. PubMed ID: 25290169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.
    Weinmann A; Alt Y; Koch S; Nelles C; Düber C; Lang H; Otto G; Zimmermann T; Marquardt JU; Galle PR; Wörns MA; Schattenberg JM
    BMC Cancer; 2015 Apr; 15():210. PubMed ID: 25884354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B; Qiao L; Hebbard L
    World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.
    Morita Y; Ueno T; Sasaki N; Kuhara K; Yoshioka S; Tateishi Y; Nagata E; Kage M; Sata M
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):277S-81S. PubMed ID: 16385236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
    Kuramoto J; Arai E; Tian Y; Funahashi N; Hiramoto M; Nammo T; Nozaki Y; Takahashi Y; Ito N; Shibuya A; Ojima H; Sukeda A; Seki Y; Kasama K; Yasuda K; Kanai Y
    Carcinogenesis; 2017 Mar; 38(3):261-270. PubMed ID: 28426876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.
    Takakura K; Oikawa T; Tomita Y; Mizuno Y; Nakano M; Saeki C; Torisu Y; Saruta M
    World J Gastroenterol; 2018 May; 24(18):1989-1994. PubMed ID: 29760542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer.
    Lau JKC; Zhang X; Yu J
    Adv Exp Med Biol; 2018; 1061():139-147. PubMed ID: 29956212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    Hwang A; Shi C; Zhu E; Naaz F; Zhou P; Rasheed Z; Liu M; Jung LS; Duan B; Li J; Jiang K; Paka L; Gadhiya SV; Dana D; Ali Q; Yamin MA; Goldberg ID; Narayan P
    PLoS One; 2018; 13(6):e0198937. PubMed ID: 29944670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.